Taltz® Injection for Plaque Psoriasis

Taltz® is a prescription biologic injection for adults with certain inflammatory conditions. It helps reduce plaques and joint symptoms by targeting interleukin-17A. This guide summarizes usage, safety, and access options with US delivery from Canada. If you need estimates for Taltz price without insurance, see the Pricing and Access section below.

CanadianInsulin.com is a prescription referral platform. We verify prescriptions with your prescriber when required, and licensed Canadian pharmacies dispense your order.

What Taltz Is and How It Works

This medicine contains ixekizumab, a monoclonal antibody that binds IL-17A. IL-17A is a cytokine involved in inflammation and plaque formation in psoriasis and related arthritides. By selectively blocking this pathway, the treatment can reduce skin lesions and help relieve joint symptoms. It is given as a subcutaneous injection using either an autoinjector or a prefilled syringe.

For cost details, including Ixekizumab autoinjector price, see Pricing and Access.

Who It’s For

The treatment is approved for adults with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy. It is also indicated for active psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. Learn more about these conditions in our resources for Psoriasis, Psoriatic Arthritis, and Axial Spondyloarthritis.

People with an active infection should not start this therapy. Those with a history of recurrent infections or inflammatory bowel disease should discuss risks. Tell your healthcare professional about current medicines and vaccines.

Dosage and Usage

Initial dosing often begins with a loading dose. For plaque psoriasis, many regimens use 160 mg at week 0 (two injections), followed by 80 mg at regular intervals. A maintenance schedule typically follows every 4 weeks. For psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis, your prescriber may start with a loading dose, then continue at a fixed interval.

Administer the injection subcutaneously into the thigh, abdomen (away from the navel), or upper arm if someone else gives the dose. Rotate injection sites. Allow the device to reach room temperature as directed before use. Do not shake. Use each device only once and dispose of it properly.

Coverage and budgeting differ by plan; Taltz cost per injection may vary based on device and quantity.

Strengths and Forms

Common presentations include single-use autoinjectors and prefilled syringes. A frequently dispensed strength is 80 mg/mL per 1 mL device. Availability can vary by pharmacy and time.

Ask your prescriber which device is suitable for you. If comparing options for ease of use, storage, or device features, see published instructions for each presentation. Pricing can differ by device; Ixekizumab prefilled syringe price is listed alongside autoinjector options in the Pricing and Access section.

Missed Dose and Timing

If a scheduled injection is missed, use it when remembered. Then take the next dose on the regular day. If you are unsure how to adjust the schedule, consult the official label or your prescriber. Avoid doubling doses to make up for a missed one.

Storage and Travel Basics

Store unopened devices in a refrigerator, protected from light. Do not freeze. Keep in the original carton. If needed, the device may be kept at room temperature for a limited time as described on the official label; do not return it to the refrigerator once stored at room temperature. Do not use if the solution is cloudy, discolored, or has particles.

For travel, carry the medicine in an insulated pack with coolant, following airline rules. Keep it with you rather than in checked baggage. Bring your prescription and a copy of the label or a letter from your prescriber. Pack an extra device when permitted in case of delays. Packaging and device selection can affect total expenses; Ixekizumab 80 mg/mL price may vary by presentation and fulfillment source.

Pen Handling and Sharps Disposal

Read the device instructions before the first dose. Wash hands. Inspect the solution through the window. Choose an injection site as directed, clean with an alcohol swab, and let dry. Place and activate the autoinjector or gently push the syringe plunger at a steady pace until the full dose is delivered. Confirm the completion indicator, when present, before removing the device.

Never recap needles. Dispose of used devices in an FDA-cleared sharps container. If you do not have one, use a heavy-duty household container with a tight, puncture-resistant lid, following local rules. Keep sharps out of reach of children and pets.

Benefits

As an IL-17A inhibitor, this therapy can reduce plaque thickness and scaling, and may ease joint pain and stiffness in related conditions. The device formats are designed for at-home use after training, which can simplify ongoing care for many adults. Fixed-interval dosing can make reminders and planning easier for long-term management.

Side Effects and Safety

• Injection site reactions
• Upper respiratory symptoms, such as runny or stuffy nose
• Nausea
• Fungal skin infections

Serious risks can include infections that may become severe, hypersensitivity reactions, and worsening of inflammatory bowel disease in susceptible patients. Your prescriber may evaluate for tuberculosis risk before starting and during treatment. Seek urgent care for signs of severe infection or allergic reaction.

Drug Interactions and Cautions

Avoid live vaccines during treatment and shortly before starting. Tell your clinician about all immunosuppressive therapies, including biologics and corticosteroids. The overall risk of infection can increase when combining agents that suppress the immune response. Discuss pregnancy and breastfeeding plans with your prescriber.

For broader reading on autoimmune care, see our article Diabetes And Autoimmune, and background comparisons in Ustekinumab Vs Adalimumab.

What to Expect Over Time

Skin and joint symptoms may change gradually with consistent dosing. Many patients continue on a maintenance schedule for long-term control if the therapy is effective and well tolerated. Your clinician may monitor skin response, joint symptoms, and infection risk at follow-up visits. Plan for periodic assessments and discuss any new symptoms promptly. Budgeting can include monthly refills or multi-pack supplies, depending on the regimen and insurer rules, along with annual cost planning.

Compare With Alternatives

Other approved biologics in similar conditions include IL-17A and TNF inhibitors. IL-17A inhibitor Cosentyx® is an alternative with different dosing and device design. TNF inhibitor Humira® is used across several inflammatory diseases and has distinct safety considerations. Your prescriber can help match therapy to diagnosis, comorbidities, and prior treatment response.

Pricing and Access

We list transparent options for device type and quantity, with Canadian pricing clearly shown. Taltz cash price reflects the selected presentation and your prescribed quantity. For current options that Ships from Canada to US, review the product page and add items to your cart to see applicable choices.

Check for seasonal offers on our Promotions page. Use our encrypted checkout and upload your prescription during checkout. Savings vary by patient and plan. To review current pricing, select your device and quantity in the cart and follow the prompts.

Availability and Substitutions

Stock status can vary by device and pack size. If an item is temporarily unavailable, your prescriber may recommend a comparable presentation or an alternative in the same class. For reference, Ixekizumab price from Canada is shown per device to help compare options. Brand substitution is not advised without prescriber approval.

Patient Suitability and Cost-Saving Tips

Good candidates include adults with indicated conditions who can adhere to regular injections and monitoring. People with active infections or significant uncontrolled comorbidities may need additional evaluation first. For lower out-of-pocket costs, consider multi-month orders when appropriate, set refill reminders, and coordinate with your prescriber to minimize missed doses.

When traveling, plan for refrigeration and documentation. Keep a spare device if permitted by your prescription. Review your plan’s specialty pharmacy rules and prior authorization needs. If paying in cash, compare device formats and quantities to find a suitable balance between convenience and overall expense.

Questions to Ask Your Clinician

• Is an IL-17A inhibitor appropriate for my diagnosis and history?
• Should I start with a loading dose, and what schedule follows?
• How will we monitor for infections or IBD worsening?
• Which device suits my dexterity and comfort with self-injection?
• What is the plan if my response plateaus or wanes?
• Are there vaccine updates I should complete before starting?
• How should I manage travel and storage for longer trips?

Authoritative Sources

Taltz Prescribing Information (Eli Lilly)

DailyMed: Ixekizumab Injection

Health Canada Drug Product Database

Ready to proceed? Start your order for US shipping from Canada with prompt, express, cold-chain shipping. This page is informational and does not replace the advice of a licensed healthcare professional.